# Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor

> **NCT00006734** · PHASE3 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 587 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **DRUG:** vincristine sulfate
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy
- **RADIATION:** brachytherapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00006734
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2006-08
- **Final completion:** 2023-06-30
- **Target enrollment:** 587 (ACTUAL)
- **Last updated:** 2023-08-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006734, "Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00006734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*